SEK 21.6
Key Takeaways
Risk factor
Very high price volatility
Profitability factor
Very favourable analyst view
About
Magle Chemoswed Holding AB (publ) engages in the research, development, and manufacturing in the areas of pharmaceutical chemistry and pharmaceutical technology in Sweden. The company focuses on the process development and manufacture of active pharmaceutical ingredients (API); and research, development, and production of products in the areas of wound care and diagnostics with a focus...
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBITD.
Target Price
The average target price of MAGLE.ST is 40 and suggests 85% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
